Primary Site >> Liver Cancer
Gene >> PRC1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. PMID: 21825042 |
Ref: Genetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma. PMID: 26693053 |
Ref: The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/beta-catenin signalling pathway. PMID: 26941395 |
Ref: Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients. PMID: 28382142 Ref: Atypical regulators of Wnt/beta-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma. PMID: 28429652 Ref: PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway. PMID: 28646916 |
Ref: Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway. PMID: 29097204 Ref: The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival. PMID: 29187402 Ref: Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis. PMID: 29670361 Ref: Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma. PMID: 29748662 Ref: BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer. PMID: 30096458 Ref: MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma. PMID: 30145863 |